Study the technical validity and feasibility of serum HER-2/Neu and its correlation with tissue HER-2 status in female breast cancer patients only. (2023). Asian Journal of Medical Sciences, 14(11), 228-233. https://doi.org/10.3126/ajms.v14i11.55260 (Original work published 2023)